Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bolan

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
The Journal of Infectious Diseases|November 1, 1985
Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzersG Bolan, A L Reingold, L A Carson, et al.
The New England Journal of Medicine|July 31, 1997
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study GroupR T Rolfs, M R Joesoef, E F Hendershot, et al.
JAMA|October 20, 1998
Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study GroupM L Kamb, M Fishbein, J M Douglas, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
The Journal of Infectious Diseases|November 1, 1985
Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzersG Bolan, A L Reingold, L A Carson, et al.
The New England Journal of Medicine|July 31, 1997
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study GroupR T Rolfs, M R Joesoef, E F Hendershot, et al.
JAMA|October 20, 1998
Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study GroupM L Kamb, M Fishbein, J M Douglas, et al.
Pageof 7